The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
so big buy just came in for around 150K wonder what he/she knows...
Still though I just don't understand how tks management thinks a reduction of value from 125m to 72m is a strong outcome
:) It's also my kind of boring, no jazz just solid performance and strong team. This has been one of the good tip that I've followed from ST
Nice divi increase as eluded to during the presentation. Love this boring company. Maybe we'll be at 0.7 per quarter by q3 2022...
Yep. Great presentation and looks like another hike for next divi is coming (if I read between the line correctly)
In regards to fool's dividend insight, according to Duke's policy we should be getting a big rise in divi soon as their dividend policy state between 7-8 percent so new investor will get growth and divi. What's not to like
" Dividend Policy
Following Shareholders' approval of the new Investing Policy in June 2015, Duke's focus has been on bringing royalty investing to the European market with the objective of generating predictable and stable cash flows from royalty agreements with a view of paying an attractive, growing and sustainable cash dividend yield for Shareholders.
Although the Company has never paid a dividend, it is the Directors' intention to start paying dividends in the financial year ending 31 March 2018 and that the Company will, in normal circumstances, pay out approximately 80 - 100 per cent. of its free cash flow to its shareholder in the form of dividends. With the proceeds of the Fundraising, the Company is targeting an annualised dividend yield of between 7 and 8 per cent. once fully invested with a minimum targeted dividend yield of at least 5 per cent in the financial year to 31 March 2018*. It is intended that, any dividend paid by the Company will be paid on a quarterly basis on or around, the end of each calendar quarter.
* This is a target only and not a profit forecast. There can be no assurance that the target can or will be met in this timescale or at all and should not be taken as an indication of the Company's expected or actual future results. Accordingly, potential investors should not place any reliance on this target in deciding whether or not to invest in the Company or assume that the Company will make any distributions at all and should decide for themselves whether or not the target dividend yield is reasonable or achievable"
https://www.fool.co.uk/2021/12/06/this-aim-listed-penny-stock-could-be-a-great-buy-for-me-in-2022/
Lets hope we can stay above 260p going into the wkend. Will bode well for year end
surely we should be over 50p now. Guess we'll get there when DUKE increase divi maybe
Finally broken 250p. Lets hope we can maintain it from here on up
Cracking result. Definitely worth the boring money @metis. Now lets see how much the divi will increase by for next payment. With all the free cash left for deployment sp could move a bit further still I think.
Agreed. Attractive enough to sit tight. Shame I first went into CRS at 172 so if we get 50p back I'll just recoup my initital investment but glad I average down so after all this I might actually be in some sort of profit
Can anyone see anything other than CRS vote pass to begin winding up ?
I'm in at 10.65. Happy for a quick 30% by end of next week?
Wow just noticed the 400K buy going through. That's a great sign, hopefully we'll get past 110p tomorrow and keep on moving up
Thank you for for the detailed discussions. Bottom line for me is that sitting tight right not and ride the waves will probably be best outcome. Whatever options we end up with the sp is definitely going to be quite a bit higher than where we are right not :)
even its small legacy business is generating income so could become a shell after until all business is done I suppose